Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells

Ignazia Tusa1, Giulia Cheloni1, Martina Poteti2

  • 1Department of Experimental and Clinical Biomedical Sciences, Università degli Studi di Firenze, viale G.B. Morgagni, 50, Firenze 50134, Italy; Istituto Toscano Tumori (ITT), Firenze 50134, Italy.

Stem Cell Reports
|September 25, 2018
PubMed

Insights

Targeting the MEK5/ERK5 pathway effectively reduces chronic myeloid leukemia (CML) cell growth and stem cell populations. This approach offers a promising alternative to tyrosine kinase inhibitors (TKIs) for CML stem cell eradication.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Tyrosine kinase inhibitors (TKIs) are standard CML treatment but fail to eliminate leukemia stem cells (LSCs), leading to relapse.
  • Leukemia stem cell maintenance is influenced by the bone marrow microenvironment, including low oxygen conditions.

Purpose of the Study:

  • To investigate the MEK5/ERK5 pathway as a potential therapeutic target for LSCs in chronic myeloid leukemia (CML).
  • To identify novel therapeutic strategies alternative to BCR/ABL targeting for CML stem cell suppression.

Main Methods:

  • Investigated the MEK5/ERK5 pathway in CML patient-derived cells and cell lines under low oxygen conditions.
  • Assessed the efficacy of MEK5/ERK5 inhibitors versus TKIs on CML cell growth in vitro and in vivo.
  • Evaluated effects on leukemia stem cell properties like culture repopulation ability (CRA) and long-term culture-initiating cells (LTC-ICs).

Main Results:

  • MEK5/ERK5 pathway inhibition significantly reduced CML cell growth in vitro and in vivo.
  • MEK5/ERK5 inhibitors, unlike TKIs, markedly reduced CRA, serial colony formation, LTC-ICs, and CD26+ cells in CML samples.
  • MEK5/ERK5 inhibition demonstrated efficacy against CML cells irrespective of imatinib resistance and spared normal hematopoietic stem cells.

Conclusions:

  • The MEK5/ERK5 pathway is crucial for maintaining CML stem cells, particularly in the stem cell niche.
  • Targeting the MEK5/ERK5 pathway presents a novel and effective therapeutic strategy for eradicating CML progenitor and stem cells.
  • This approach may overcome TKI resistance and reduce CML relapse rates.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.6K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K